IRCT20240610062069N1招募中1 期
: Phase I trial of first-in-human CAR NK–targeting EGFRvIII in patients with metastatic breast cancer.
omid cell and tissue processing company0 个研究点目标入组 6 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- Female
入选标准
- •patients with metastatic breast cancer
- •written informed consent form
排除标准
- •Pregnant or breastfeeding women
- •Infected with HIV, HBV,HCV
- •Using immune suppressor drugs
研究者
相似试验
招募中
1 期
CAR-NK Targeted CD19 for r/r B-cell MalignanciesAdult Relapsed/Refractory B-cell Hematologic MalignanciesNCT05645601Affiliated Hospital to Academy of Military Medical Sciences12
Unknown
1 期
Pilot Study of NKG2D-Ligand Targeted CAR-NK Cells in Patients With Metastatic Solid TumoursSolid TumoursNCT03415100The Third Affiliated Hospital of Guangzhou Medical University30
已完成
不适用
atural Killer (NK) Cell Therapy Combined with Hepatic Artery Infusion Chemotherapy (HAIC) in Patients with Advanced Hepatocellular CarcinomaNeoplasmsKCT0004642Vaxcell-Bio20
已完成
不适用
Phase I clinical trial using a novel CCK-2/gastrin receptor-localizing radiolabelled peptide probe for personalized diagnosis and therapy of patients with progressive or metastatic medullary thyroid carcinomamedullary thyroid carcinomaNL-OMON46298Azienda Ospedaliero-Universitaria Pisana5
尚未招募
2 期
Phase II Clinical Trial: Efficacy and Safety of Kaempferia Parviflora in Treatment of Chronic Vertigo PatientsDizzinessKaempferia parviflora,chronic vertigo,Dizziness Handicap Inventory,Vestibular functionTCTR20181122001Agricultural Research Development Agency (Public Organization)72